232 related articles for article (PubMed ID: 22891286)
1. Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.
Coler RN; Bertholet S; Pine SO; Orr MT; Reese V; Windish HP; Davis C; Kahn M; Baldwin SL; Reed SG
J Infect Dis; 2013 Apr; 207(8):1242-52. PubMed ID: 22891286
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial.
Day TA; Penn-Nicholson A; Luabeya AKK; Fiore-Gartland A; Du Plessis N; Loxton AG; Vergara J; Rolf TA; Reid TD; Toefy A; Shenje J; Geldenhuys H; Tameris M; Mabwe S; Bilek N; Bekker LG; Diacon A; Walzl G; Ashman J; Frevol A; Sagawa ZK; Lindestam Arlehamn C; Sette A; Reed SG; Coler RN; Scriba TJ; Hatherill M;
Lancet Respir Med; 2021 Apr; 9(4):373-386. PubMed ID: 33306991
[TBL] [Abstract][Full Text] [Related]
3. Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone.
Thakur A; Pinto FE; Hansen HS; Andersen P; Christensen D; Janfelt C; Foged C
Front Immunol; 2020; 11():803. PubMed ID: 32457748
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination.
Chuang YM; Dutta NK; Gordy JT; Campodónico VL; Pinn ML; Markham RB; Hung CF; Karakousis PC
Front Immunol; 2020; 11():680. PubMed ID: 32411131
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic vaccination: hope for untreatable tuberculosis?
McMurray DN
J Infect Dis; 2013 Apr; 207(8):1193-4. PubMed ID: 22891288
[No Abstract] [Full Text] [Related]
6. Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.
Guirado E; Gil O; Cáceres N; Singh M; Vilaplana C; Cardona PJ
Clin Vaccine Immunol; 2008 Aug; 15(8):1229-37. PubMed ID: 18524883
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
Baldwin SL; Reese VA; Larsen SE; Beebe E; Guderian J; Orr MT; Fox CB; Reed SG; Coler RN
PLoS One; 2021; 16(3):e0247990. PubMed ID: 33705411
[TBL] [Abstract][Full Text] [Related]
8. Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidate.
Windish HP; Duthie MS; Misquith A; Ireton G; Lucas E; Laurance JD; Bailor RH; Coler RN; Reed SG
Vaccine; 2011 Oct; 29(44):7842-8. PubMed ID: 21816196
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens.
Derrick SC; Yabe IM; Yang A; Kolibab K; Hollingsworth B; Kurtz SL; Morris S
Vaccine; 2013 Sep; 31(41):4641-6. PubMed ID: 23906890
[TBL] [Abstract][Full Text] [Related]
10. Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.
Duthie MS; Coler RN; Laurance JD; Sampaio LH; Oliveira RM; Sousa AL; Stefani MM; Maeda Y; Matsuoka M; Makino M; Reed SG
Infect Immun; 2014 Sep; 82(9):3979-85. PubMed ID: 25024362
[TBL] [Abstract][Full Text] [Related]
11. The importance of adjuvant formulation in the development of a tuberculosis vaccine.
Baldwin SL; Bertholet S; Reese VA; Ching LK; Reed SG; Coler RN
J Immunol; 2012 Mar; 188(5):2189-97. PubMed ID: 22291184
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon.
Troy A; Esparza-Gonzalez SC; Bartek A; Creissen E; Izzo L; Izzo AA
Tuberculosis (Edinb); 2020 Jul; 123():101949. PubMed ID: 32741537
[TBL] [Abstract][Full Text] [Related]
13.
Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
[TBL] [Abstract][Full Text] [Related]
14. Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate.
Baldwin SL; Reese VA; Huang PW; Beebe EA; Podell BK; Reed SG; Coler RN
Clin Vaccine Immunol; 2016 Feb; 23(2):137-47. PubMed ID: 26656121
[TBL] [Abstract][Full Text] [Related]
15. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.
Kita Y; Hashimoto S; Nakajima T; Nakatani H; Nishimatsu S; Nishida Y; Kanamaru N; Kaneda Y; Takamori Y; McMurray D; Tan EV; Cang ML; Saunderson P; Dela Cruz EC; Okada M
Hum Vaccin Immunother; 2013 Mar; 9(3):526-33. PubMed ID: 23249609
[TBL] [Abstract][Full Text] [Related]
17. The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice.
Kao FF; Mahmuda S; Pinto R; Triccas JA; West NP; Britton WJ
PLoS One; 2012; 7(5):e34991. PubMed ID: 22567094
[TBL] [Abstract][Full Text] [Related]
18. Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.
Orr MT; Ireton GC; Beebe EA; Huang PW; Reese VA; Argilla D; Coler RN; Reed SG
J Immunol; 2014 Sep; 193(6):2911-8. PubMed ID: 25086172
[TBL] [Abstract][Full Text] [Related]
19. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
20. Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs.
Liang Y; Wu X; Zhang J; Yang Y; Wang L; Bai X; Yu Q; Li N; Li Z
Scand J Immunol; 2011 Jul; 74(1):42-6. PubMed ID: 21352251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
